mito-
Cancer drugs that damage the cell nucleus (stem no longer in use).
- Drugs starting with mito-: 10
- Approved somewhere: 4
- With a US drug page: 3
- Stem
- mito-
- Class
- Cancer drugs that damage the cell nucleus (stem no longer in use)
Approved and clinical-stage drugs in ChEMBL whose names starting with mito-, matched by spelling; those with a US drug page link to it.
| Acts on | |||
|---|---|---|---|
| Mitomycin | Approved | DNA | DNA inhibitor |
| Mitotane | Approved | CYP11A1, CYP11B1 | Cytochrome P450 11A1 inhibitor |
| Mitoxantrone | Approved | TOP2A, DNA | DNA topoisomerase II alpha inhibitor |
| Mitobronitol | Approved | DNA | DNA disrupting agent |
| Mitoguazone | Phase 3 | — | — |
| Mitolactol | Phase 3 | — | — |
| Mitomycin a | Phase 3 | — | — |
| Mitoglitazone | Phase 2 | — | — |
| Mitoquinol cation | Phase 2 | — | — |
| Mitoquinone cation | Phase 2 | — | — |
Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO